Term
Beta- Andenergic Blocking Agents
-metoprolol (Toprol)
-bisporlol (Zebta)
-atenolol (Tenormin)
-Propanolol (Inderal) |
|
Definition
MOA- Blocks Beta-1 receptors decreases HR, inhibits renin release from kidneys
Uses:Initial therapy for stage 1& 2 HTN
C.S.E- Bradycardia, masks hypoglycemia in Diabetic Patients
|
|
|
Term
Diuretics
(Loop)
-furosemide (lasix)
-metolazone (Zaroxolyn)
ethacrynic acid (Edecrin)
-bumetanide (Bumex) |
|
Definition
MOA- Deplets volume, sodium excretion, vasodialation of peripheral arterioles |
|
|
Term
Diuretics
(Thiazides)
-hydrochlorothiazide
|
|
Definition
MOA- Deplets volume, sodium excretion, vasodialtaion of peripheral arterioles |
|
|
Term
Transdermal Contaceptives
morelgetromin-Ethinyl estradiol transdermal system
(ortho Evra)
|
|
Definition
MOA- Inhibits ovulation
Uses- estrogen and progestin in patch form
S.E-Blurred vision, leg pain |
|
|
Term
Oral Contraceptives
-Combination Pill
-Mini Pill
- Extended and Continuous |
|
Definition
Combintaion- taken for 21 days of menstral cycle, estrogen and progestin
Subdivied - monophasic, biphasic, triphasic
Mini Pill- taken everyday - only progestin
Extended and Continuous - 24 or 84 day cycles followed by a short placebo period |
|
|
Term
Oral Contraceptives
-Estrogen - Blocks pituitary release of FSH
- Progestins - Inhibit Pituitary Release of LH
|
|
Definition
MOA- Induce contraception by inhibinting ovulation
S.E.- Break through bleeding, leg pain, chest pain, SOB |
|
|
Term
|
Definition
Common cause of lower reproduction tract infections
-candida albicans
-trichomonas vaginalis
- gardnerella vaginalis |
|
|
Term
Other Agents
Phytonadione
|
|
Definition
MOA- fat soluable vitamin K fot the production of blood clotting factors
Uses- Administered prophylactically to protect against hemorrhagic diseas of the the new born
S.E- brusing , hemorrhage |
|
|
Term
Other Agents
Erythromycin Ophthalmic Ointment
(Ilotycin) |
|
Definition
MOA & Uses- macrolide antibiotic used prophylactically to prevent opthalmia neonatorum, effective against C. trachomatis
S.E.- mild conjunctivitis |
|
|
Term
Other Agnets
- Rho (D) immune globulin |
|
Definition
Suspress stimulation of actice immunity by Rh-positive foreign body cells, prevent Rh hemolytic disease in new borns
Uses- Prevent Rh immunization fo Rh- negative patient exposed to Rh- positive blood
S.E.- localized tenderness, generalized aches and pains |
|
|
Term
Other agents
-clomiphene citrate
(Clomid) |
|
Definition
MOA- stimulate ovaries to release ova for potential fertilization
Uses- induce ovulation in woment with low estrogen levels
SE- sever abdominla cramps visual disturbance |
|
|
Term
Uterine relaxants
Terbutaline sulfate
(Brethine) |
|
Definition
MOA - Beta 1 & 2 agonist produces telaxation of uterine , bronchial and vasculat smooth musce Increased HR
uses- STOP premature labor wehn no underlying pathology indicates pregnancy be discontinued
se- tachycardia, palpitaions, HTN |
|
|
Term
Uterine telaxants
-magnesium sulfate |
|
Definition
moa- anticonvulsant effect, smooth muscle, relaxation, inhibit uterine muscle contractions
uses - inhibit preterm labor, controll seizure activity, associated with preeclampsia, and eclampsia
se- confusion, decreased urine out put.
ANTIDOTE FOR MAGNESIUM TOXICITY |
|
|
Term
UTERINE STIMULANTS
-oxytocin (Pitocin) |
|
Definition
moa- stimulats uterine smooth muscle, blood vessels, mammary glands
uses - initiate active labor in 3rd trimester, postpartum uterine atony controll, and hemorrhage
se- hypotension, HTN, H2O intocicaiton, dehydration, hemorrhage |
|
|
Term
Uterine stimlants
-ergonovine (Ergotrate meleate)
-methylergonovine (Methergine) |
|
Definition
moa- Directly simulate uterine contractions
uses controll bleeding and maintain firmness in postpartum patients
SE- HTN |
|
|
Term
Uterine stimulants
-misprostol
(Cytotec) |
|
Definition
moa- causes uterine contraction in pregnancy
uses - cervical ripening agent, induce labor, serious postpatum hemorrhage
se- orthostatic hypotension |
|
|
Term
uterine stimulants
-Dinoprostone
(prostin E2, Prepidil, Cervidil) |
|
Definition
MOA- uterine and GI smooth muscle stimulant, start and contunue cervical ripening at term
uses- expell uterine contents after fetal death,
se- orthostatic hypotension |
|
|
Term
|
Definition
implementation of fertilized ovum, continuation of pregnancy, brepares breats for lactation |
|
|
Term
|
Definition
breast, voice quality, broard pelvis and menstruation development |
|
|
Term
|
Definition
|
|
Term
Antiandrogen Agents
-Dutastride (Avodart)
-Finasteride (Proscar)
|
|
Definition
moa- inhibie enxyme 5-alpha reductase lowers DHT levels
uses - Treats BPH, reduces risk of urinary retention and reduces the need for surgery in BPH patients
SE- impotence, decreased libido and volume of ejaculate
FINASTERIDE - S.E.- male pattern baldness |
|
|
Term
Alpha-1 Andernergic Blocking agents
-Terasozin
-Tamsulosin (Flomax) |
|
Definition
moa- block alpha-1 receptors of the prostate gland, muscle relaxing , increases outflow
uses- reduce mild to moderate urinary obstruction in men w/BPH
se- tachycardia, fainting |
|
|
Term
Phosphodiesterase Inhibitors
-sildenafil (Viagra)
- tadafil (Cialis)
- vardenafil (Levitra)
|
|
Definition
moa- selectice inhibitor of PDE-5 enzyme
Uses- erectile dysfunction, pulmonayr arterial hypertension
Se- hypotension, sustained erection, loss of vistion |
|
|
Term
Direct Renin Inhibitors
-aliskiren (Tekturna) |
|
Definition
moa- block 1st step in RAAS cascade prevention release of aldosterone
uses- antihypertensive, reduce B/P
SE - altered fluid and electrlytes, Birth defects |
|
|
Term
ARBs (angiotensin receptor blockers)
-valsartan (Diovan)
- Olmesartan (Benicar)
-losartan (Cozaar)
|
|
Definition
moa- binds to angiotensin 2 receptor sites and block the vasoconstrictor from binding to receptor sites in targes organs
Uses- reduce B/P
se- hyperkalemia, birth defects |
|
|
Term
Intrabaginal Hormonal Contraceptive
etonogestrel-ethinyl estradiol vaginal ring
(Nuva Ring) |
|
Definition
MOA- Estrogen and progestin inhibit ovulation
uses - plastic ring dosage form instered into vagina
se- leg pain, chest pain, SOB |
|
|
Term
ACE Inhibitors (angiotensin converting enzyme)
-lisinopril (Privinil)
-catopril
-enalapril (Vasotec)
-ramipril (Altace) |
|
Definition
moa- inhibit angiotensin I convering enzyme disrupting the conversion. ACE I-> ACE II
uses- single therapy for stage 1 or 2 htn
se- COUGH |
|
|
Term
Miscellaneous Antilipemic Agents
-omega - 3 fatty acids (Lovaza) |
|
Definition
moa- decrease synthesis of triglycerides in liver
ACTIVE INGREDIENTS OF EPA AND DHA
USES- combo treatment w/ dietary therapy to decrease the increase of triglyceride levels
se- back and abdominal pain |
|
|
Term
Miscellaneous Antilipmic Agents
-ezetimibe (Zetia) |
|
Definition
moa- block absorption of cholestrole from small intestine
uses - combo treatment w/ dietary therapy to decrease increased chloesterol
se- abdominal pain
SHOULD BE USED IN COMBO |
|
|
Term
Fibric acids
-Gemfibrozil (Lopid)
-Fenofibrate (Tricor)
|
|
Definition
moa- decrease triglyceride levels
uses- combo treatment with dietary therapy to treat hypertriglyceridemia
S E -malaise, jaundice |
|
|
Term
HMG-CoA reductase Inhibitors
(Statins)
-Tosuvastatin (Crestor)
-Atorcastatin (Lipitor)
-Simvastatin (Zocor)
|
|
Definition
moa- inhibit enzymes responsible for converting HMG-CoA to mevalonate, decrease liver cholesterol
uses- combo w/ diatary therapy to decrease LDL and total cholestrol levels
SE- liver dysfuction, myoapthy, RHABDOMYOLYSIS
Pregnancy category X
|
|
|
Term
NIACIN (NICOTINC ACID) Vit B3
|
|
Definition
moa- inhibits VLDL synthesis by liver cells
Best to increase HDL
uses - treatment of dyslipidemies, lower risk of CAD
SE- Hepato tozicity , myopathy, HTN
DO NOT GIVE IN PEPTIC ULCER DISEASE |
|
|
Term
Bil Acid - Binding Resins
-Cholestyramin
-Colestipol
-Colesevelum
MUST BE GIVEN WITH MEALS
|
|
Definition
MOA- Binds to bile acids, promotes increased metabolism of cholesterol
uses - in combo with dietary therapy to decrease increased cholesterol
SE - constipation, Vit K deficiency |
|
|
Term
Directy Vasodilator
-Hydralazine (Apersolin)
-Minoxidil (Loniten)
-Nitroprusside (Nitropress) |
|
Definition
moa- relax arteriel smooth muscle, decrease peripheral bascular resistance
uses - treats stage 2 HTN, renal disease HTN
SE - palpitation, tachycardia, Hair growth |
|
|
Term
Central - Acting Alpha-2 Agnoists
-Clonidine (Catapress)
-Methyldopa |
|
Definition
moa- stimulats alpha-adernergic recptors in the brainstem, reducing sympathetic out flow from the CNS
uses- used only in combination
SE- Depression, Rash |
|
|
Term
Alpha-1 Adrenergic Blocking Agents
-doxasozin (cardura)
-prazosin (Minipress)
-Terazosin (Hytin)
|
|
Definition
moa - block postsynaptic alpha-1 receptors to produce vasodialation, decrease peripheral vascular resistance
uses- decrease B/P, Decreas mild to moderate urinay obstruction (BPH in men)
SE- tachycardia, dizziness |
|
|
Term
Calcium Channel Blockers
DIHYDROPYRIDINES
-amlodipine (Norvasc)
-bepridil (Cascor)
-felodipine (Plendil)
|
|
Definition
moa- dilates the arteris
Uses- HTN, A-FIB
SE- Hypotension, syncope, edema |
|
|
Term
Calcium Channel Blockers
NONDIYDROPYRIDINES
-diltiazem (Cardizem)
-verapamil (Calan) |
|
Definition
moa - inhibits the transportation of Calcium in to the myocardial and casculat smooth muscle reduces mycardial comtractabily and demant for oxygen
Uses- A-FIB, 1st or 2nd line of HTN
SE- Hypotension, syncope, edema |
|
|